Developments in the pharmacology and therapeutics of parkinsonism
- 1 February 1977
- journal article
- review article
- Published by Wiley in Annals of Neurology
- Vol. 1 (2), 111-119
- https://doi.org/10.1002/ana.410010202
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- BROMOCRIPTINE AND LEVODOPA (WITH OR WITHOUT CARBIDOPA) IN PARKINSONISMThe Lancet, 1976
- Bromocriptine treatment in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- EFFECT of CB 154 (2-BROMO-ALPHA-ERGOCRYPTINE) ON PARALYSIS AGITANS COMPARED WITH MADOPAR IN A DOUBLE-BLIND, CROSS-OVER TRIALActa Neurologica Scandinavica, 1976
- BROMOCRIPTINE IN PARKINSONISMThe Lancet, 1975
- Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidolLife Sciences, 1975
- IDIOPATHIC PARKINSONISM TREATED WITH BROMOCREPTINEThe Lancet, 1975
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal of Neural Transmission, 1975
- Bromocriptine treatment of acromegaly.BMJ, 1975
- Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with LevodopaBMJ, 1971
- Monoamine oxidase inhibitors and L-dopa.BMJ, 1970